False positives in BlaR1 inhibitor screening present a major hurdle in developing novel β-lactamase potentiators for antibiotic resistance.
This article provides a comprehensive analysis of efficacy metrics for BlaR1 inhibitor resistance reversal, targeted at drug development professionals and antimicrobial resistance researchers.
This review provides a comprehensive analysis of the molecular and clinical mechanisms driving resistance to β-lactamase repressor (BlaR1) inhibitors, a critical emerging challenge in combating antimicrobial resistance (AMR).
This comprehensive guide details the development, optimization, and application of high-throughput screening (HTS) assays for identifying novel BlaR1 inhibitors, a critical strategy in combating β-lactam antibiotic resistance.
This article provides a comprehensive comparative analysis of BlaR1 and MecR1, the key signal-transducing transcriptional regulators of β-lactamase and PBP2a expression in methicillin-resistant *Staphylococcus aureus* (MRSA).
This article explores the intricate landscape of BlaR1 inhibitor cross-reactivity with structurally related sensor domains, a critical consideration for the development of novel β-lactamase inhibitor adjuvants.
This article provides a comprehensive analysis for researchers and drug development professionals comparing two distinct strategies to combat β-lactamase-mediated antibiotic resistance.
This article provides a comprehensive analysis of BlaR1 fragmentation site mutations, a critical mechanism in bacterial antibiotic resistance.
This article provides a comprehensive analysis of BlaR1, the signal-transducing membrane sensor for β-lactam antibiotics, focusing on its critical fragmentation and proteasome-mediated degradation as the central mechanism for signal recovery.
This article provides a detailed framework for researchers studying the BlaR1 β-lactam sensory-transducer protein.